We are live on ! Find out more
PP

Patten & Patten Portfolio holdings

AUM $1.89B
1-Year Est. Return 27.89%
This Fund
S&P 500
This Quarter Est. Return
+4.71%
1 Year Est. Return
+27.89%
3 Year Est. Return
+74.1%
5 Year Est. Return
+94.43%
10 Year Est. Return
+386.08%
AUM
$813M
AUM Growth
+$36.6M
Cap. Flow
+$8.94M
Cap. Flow %
1.1%
Top 10 Hldgs %
30.98%
Holding
228
New
10
Increased
73
Reduced
109
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.17M
2
IBM icon
IBM
IBM
+$5.05M
3
KR icon
Kroger
KR
+$2.79M
4
AMLP icon
Alerian MLP ETF
AMLP
+$2.06M
5
MSFT icon
Microsoft
MSFT
+$1.64M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.51%
2 Industrials 14.14%
3 Technology 11.3%
4 Healthcare 10.42%
5 Financials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IP icon
201
International Paper
IP
$21.9B
$223K 0.03%
4,446
IJH icon
202
iShares Core S&P Mid-Cap ETF
IJH
$127B
$219K 0.03%
6,625
-500
-7% -$15.9K
CMCSA icon
203
Comcast
CMCSA
$89.4B
$218K 0.03%
6,322
+156
+3% +$5.21K
FITB
204
Fifth Third Bancorp
FITB
$51.8B
$216K 0.03%
+8,000
New +$192K
TGT icon
205
Target
TGT
$69B
$215K 0.03%
2,975
FRC
206
DELISTED
First Republic Bank
FRC
$214K 0.03%
+2,323
New +$190K
SCHX icon
207
Schwab US Large- Cap ETF
SCHX
$74.6B
$211K 0.03%
23,820
VTI icon
208
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$211K 0.03%
+1,830
New +$206K
SHPG
209
DELISTED
Shire pic
SHPG
$204K 0.03%
1,200
HBAN icon
210
Huntington Bancshares
HBAN
$35.6B
$132K 0.02%
10,000
DXYN
211
DELISTED
Dixie Group Inc
DXYN
$113K 0.01%
31,400
+3,000
+11% +$11.7K
BDX icon
212
Becton Dickinson
BDX
$48.9B
-1,166
Closed -$205K
CVS icon
213
CVS Health
CVS
$122B
-3,094
Closed -$275K
EFA icon
214
iShares MSCI EAFE ETF
EFA
$79.8B
-4,148
Closed -$245K
ILMN icon
215
Illumina
ILMN
$29B
-1,192
Closed -$211K
JAZZ icon
216
Jazz Pharmaceuticals
JAZZ
$16.7B
-1,800
Closed -$219K
VO icon
217
Vanguard Morningstar Mid-Cap ETF
VO
$109B
-6,480
Closed -$210K
VV icon
218
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
-3,530
Closed -$350K
VYX icon
219
NCR Voyix
VYX
$1.09B
-15,078
Closed -$298K
ACBI
220
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
-11,956
Closed -$179K

Similar funds

Patten & Patten's Q4 2016 Portfolio in Review

As of Q4 2016, Patten & Patten held 228 positions worth $813M, up 4.7% from $776M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Patten & Patten's Q4 2016 filing shows 10 new, 73 increased, 109 reduced and 9 closed positions. Its largest new stake was Edwards Lifesciences: 42,174 shares worth $1.32M. The largest sale was Novo Nordisk, an estimated $2.32M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Patten & Patten's largest Q4 2016 buy was Edwards Lifesciences: 42,174 shares worth $1.32M.
  • Patten & Patten added most to Bristol-Myers Squibb in Q4 2016, an estimated $5.17M increase.
  • Patten & Patten's biggest Q4 2016 reduction was Novo Nordisk, cutting an estimated $2.32M.
  • Patten & Patten fully exited Vanguard Morningstar Large-Cap ETF in Q4 2016, selling an estimated $350K.
  • Patten & Patten's ten largest holdings make up 31% of its $813M portfolio in Q4 2016.
  • Patten & Patten opened 10 new positions and closed 9 in Q4 2016.
  • Patten & Patten's portfolio value rose 4.7% quarter-over-quarter to $813M.

Based on Patten & Patten's 13F filing for Q4 2016, filed 27 Jan 2017.